SCHEMBL3943105

SCHEMBL3943105

O=C1CC(=O)N(N2Cc3ccccc3C2)C(=O)C1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.50
▸ CYP2A6 P11509 1/20 0.43
▸ RXFP1 Q9HBX9 1/20 0.41
▸ NOTUM Q6P988 2/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ RNASEH1 O60930 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ MAOA P21397 2/20 0.35
▸ CFTR P13569 1/20 0.35
▸ GOPC Q9HD26 1/20 0.35
▸ GAA P10253 1/20 0.34
▸ PKM P14618 1/20 0.34
▸ TLR9 Q9NR96 1/20 0.34
▸ HTR7 P34969 4/20 0.34
▸ MAOB P27338 1/20 0.33
▸ BCHE P06276 1/20 0.33
▸ CES1 P23141 1/20 0.33
▸ HTR1A P08908 2/20 0.33
▸ DRD2 P14416 1/20 0.33
▸ HTR2C P28335 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29614071 0.79 MAOA (0.41) CYP1A2CYP2A6RXFP1NOTUMKMT2A
SCHEMBL5969633 0.79 MAOA (0.41) CYP1A2CYP2A6RXFP1NOTUMKMT2A
Hydrochloric Acid SCHEMBL30423571 0.78 MAOA (0.39) CYP1A2CYP2A6RXFP1NOTUMKMT2A
SCHEMBL29366435 0.69 CYP1A2 (1.00) CYP1A2CYP2A6MAOACFTRGOPC
SCHEMBL77106 0.69 CYP1A2 (1.00) CYP1A2CYP2A6MAOACFTRGOPC
SCHEMBL29765632 0.67 HPGD (0.59) CYP1A2CYP2A6NOTUMKMT2ARNASEH1
SCHEMBL10463768 0.66 CYP1A2 (0.94) CYP1A2CYP2A6KMT2AMAOACFTR
Ammonia Solution, Strong SCHEMBL13736473 0.66 CYP1A2 (0.94) CYP1A2CYP2A6MAOACFTRGOPC
SCHEMBL25433262 0.66 SRD5A1 (0.40) RXFP1NOTUMMAOAMAOB
SCHEMBL25409744 0.66 CYP1A2 (0.39) CYP1A2CYP2A6RXFP1NOTUMKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009020590-A1 METHODS FOR TREATING LYMPHOMAS IN CERTAIN PATIENT POPULATIONS AND SCREENING PATIENTS FOR SAID THERAPY CELGENE CORPORATION (US) 2009-02-12 — — WO disclosed
Send feedback